XBB.1.5: A New Threatening SARS-CoV-2 Omicron Subvariant

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2023 May 5

PMID 37143546

Authors

Md Aminul Islam

Fatema Hasan Kaifa

Deepak Chandran

Manojit Bhattacharya

Chiranjib Chakraborty

Prosun Bhattacharya

Kuldeep Dhama

Affiliations

Soon will be listed here.

Citing Articles

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants.

Chen L, He Y, Liu H, Shang Y, Guo G Front Immunol. 2024; 15:1339660.

PMID: 38464527 PMC: 10924305. DOI: 10.3389/fimmu.2024.1339660.

A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety.

Islam M Infect Med (Beijing). 2024; 2(4):247-261.

PMID: 38205179 PMC: 10774670. DOI: 10.1016/j.imj.2023.08.005.

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.

Stewart R, Yan K, Ellis S, Bishop C, Dumenil T, Tang B Front Microbiol. 2023; 14:1320856.

PMID: 38075874 PMC: 10706942. DOI: 10.3389/fmicb.2023.1320856.

Functionalized Fullerene Potentially Inhibits SARS-CoV-2 Infection by Modulating Spike Protein Conformational Changes.

Liu K, Guo F, Ma Y, Yu X, Fu X, Li W Int J Mol Sci. 2023; 24(19).

PMID: 37833919 PMC: 10572755. DOI: 10.3390/ijms241914471.

References

Sakib M, Nishat A, Islam M, Uddin M, Iqbal M, Fuad Bin Hossen F . Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2. Comput Biol Med. 2021; 136:104759. PMC: 8352665. DOI: 10.1016/j.compbiomed.2021.104759. View

Cao Y, Jian F, Yu Y, Song W, Yisimayi A, Wang J . Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2022; 614(7948):521-529. PMC: 9931576. DOI: 10.1038/s41586-022-05644-7. View

Yue C, Song W, Wang L, Jian F, Chen X, Gao F . ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5. Lancet Infect Dis. 2023; 23(3):278-280. PMC: 9897732. DOI: 10.1016/S1473-3099(23)00010-5. View

Islam M, Haque M, Rahman M, Hossen F, Reza M, Barua A . A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection. Front Immunol. 2022; 13:837290. PMC: 8965011. DOI: 10.3389/fimmu.2022.837290. View

Zhou H, Mohlenberg M, Thakor J, Tuli H, Wang P, Assaraf Y . Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant. Clin Microbiol Rev. 2022; 35(3):e0001422. PMC: 9491202. DOI: 10.1128/cmr.00014-22. View

Ahmed F, Islam M, Kumar M, Hossain M, Bhattacharya P, Islam M . First detection of SARS-CoV-2 genetic material in the vicinity of COVID-19 isolation Centre in Bangladesh: Variation along the sewer network. Sci Total Environ. 2021; 776:145724. PMC: 7870435. DOI: 10.1016/j.scitotenv.2021.145724. View

Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y . Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun. 2023; 14(1):2800. PMC: 10187524. DOI: 10.1038/s41467-023-38435-3. View

Uraki R, Ito M, Furusawa Y, Yamayoshi S, Iwatsuki-Horimoto K, Adachi E . Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB. Lancet Infect Dis. 2022; 23(1):30-32. PMC: 9729000. DOI: 10.1016/S1473-3099(22)00816-7. View

Akkiz H . The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern. Front Med (Lausanne). 2022; 9:849217. PMC: 9163346. DOI: 10.3389/fmed.2022.849217. View

10.

Wong C . Subvariant 'soup' may drive wave. New Sci. 2022; 256(3411):11. PMC: 9635891. DOI: 10.1016/S0262-4079(22)01970-4. View

11.

Dhama K, Nainu F, Frediansyah A, Yatoo M, Mohapatra R, Chakraborty S . Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health. 2022; 16(1):4-14. PMC: 9675435. DOI: 10.1016/j.jiph.2022.11.024. View

12.

Kurhade C, Zou J, Xia H, Liu M, Chang H, Ren P . Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat Med. 2022; 29(2):344-347. DOI: 10.1038/s41591-022-02162-x. View

13.

Islam M, Rahman M, Jakariya M, Bahadur N, Hossen F, Mukharjee S . A 30-day follow-up study on the prevalence of SARS-COV-2 genetic markers in wastewater from the residence of COVID-19 patient and comparison with clinical positivity. Sci Total Environ. 2022; 858(Pt 3):159350. PMC: 9576909. DOI: 10.1016/j.scitotenv.2022.159350. View

14.

Sharun K, Tiwari R, Yatoo M, Natesan S, Megawati D, Singh K . A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19. Narra J. 2024; 2(3):e92. PMC: 10914132. DOI: 10.52225/narra.v2i3.92. View

15.

Ke H, Chang M, Marasco W . Immune Evasion of SARS-CoV-2 Omicron Subvariants. Vaccines (Basel). 2022; 10(9). PMC: 9501521. DOI: 10.3390/vaccines10091545. View

16.

Fernandes Q, Inchakalody V, Merhi M, Mestiri S, Taib N, El-Ella D . Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med. 2022; 54(1):524-540. PMC: 8843115. DOI: 10.1080/07853890.2022.2031274. View